Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Jul 2017 18:28

RNS Number : 3073L
Circassia Pharmaceuticals Plc
17 July 2017
 

Persons Discharging Managerial Responsibilities / persons closely associated with them (PDMR) Notification

 

17 June 2017: Circassia Pharmaceuticals plc (LSE: CIR).

 

 

1 - Details of the person discharging managerial responsibilities/person closely associated

 

Name

Steven Harris

 

2 - Reason for the notification

 

Position/status

Chief Executive Officer (PDMR)

Initial notification/amendment*

Initial Notification

In case of amendment, please enter the previous notification reference number and explain the error that this notification needs amending

N/A

 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

Full name of entity*

Circassia Pharmaceuticals plc

Legal Entity Identifier code

2138006YAT138TOGA556

In accordance with ISO 1744 LEI code

 

4 - Details of the transaction(s)

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

Date

Description of Financial Transaction

Aggregated Price

Aggregated Volume

Total Aggregated Price

17-Jun-17

Exercise of options under the 2007 EMI scheme without sale of shares (options issued under 2007 EMI scheme expire 10 years following grant)

£0.0008

535,375

£428.30

 

 

i. Exercise of options

 

Description of the financial instrument, type of instrument

Circassia Holdings Ltd 2007 Unapproved Option Scheme

Identification Code

GB00BJVD3B28

Nature of the transaction

Exercise of options

Currency

GBP

Price(s) and Volume (s)

Price

Volume

Total

£0.0008p

535,375

£428.30

Aggregated Information

Price

Volume

Total

£0.0008p

535,375

£428.30

Date of Transaction

17 June 2017

Place of Transaction

London: XLON

 

 

For further information, please contact:

 

Circassia Pharmaceuticals plc

Julien Cotta, Company Secretary

 

+44 (0) 1865 405560

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBRGDRCBBBGRR
Date   Source Headline
1st Sep 20225:45 pmRNSChange of Company Name
1st Sep 202211:00 amRNSResult of General Meeting and Change of Name
11th Aug 20227:00 amRNSProposed Change of Name and Notice of GM
29th Jul 202210:41 amRNSTotal Voting Rights
21st Jul 20223:30 pmRNSChange of Auditor
14th Jul 20227:00 amRNSTrading Update
5th Jul 20223:57 pmRNSHolding(s) in Company
30th Jun 202211:54 amRNSTotal Voting Rights
29th Jun 202211:00 amRNSUpdate regarding Beyond Air product approval
10th Jun 20221:06 pmRNSHolding(s) in Company
31st May 202211:08 amRNSTotal Voting Rights
27th May 20229:53 amRNSExtension of Block Admission
25th May 20224:41 pmRNSSecond Price Monitoring Extn
25th May 20224:35 pmRNSPrice Monitoring Extension
20th May 20227:00 amRNSGrant of Options
12th May 202212:04 pmRNSResult of AGM
12th May 20227:00 amRNSAGM Statement
3rd May 20224:01 pmRNSChange of Registered Office
29th Apr 202210:32 amRNSTotal Voting Rights
13th Apr 20226:17 pmRNSAnnual Report and Notice of AGM
1st Apr 20227:00 amRNSBlock listing Interim Review
1st Apr 20227:00 amRNSTotal Voting Rights
29th Mar 20222:18 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSBlock Admission
22nd Mar 20227:00 amRNSPreliminary Results
31st Jan 202210:24 amRNSTotal Voting Rights
28th Jan 20222:15 pmRNSHolding(s) in Company
13th Jan 20227:00 amRNSTrading Statement
4th Jan 202210:40 amRNSTotal Voting Rights
30th Nov 20217:00 amRNSTotal Voting Rights
29th Nov 20218:54 amRNSBlock Listing Application
5th Oct 20213:06 pmRNSExtension of Block Admission
30th Sep 20213:15 pmRNSBlock listing Interim Review
21st Sep 20215:18 pmRNSHolding(s) in Company
17th Sep 20217:00 amRNSDirector/PDMR Shareholding
16th Sep 20217:00 amRNSInterim Results - Ended 30 June 2021
1st Sep 20212:52 pmRNSTotal Voting Rights
30th Jul 20217:00 amRNSTotal Voting Rights
13th Jul 20217:00 amRNSFirst Half Trading Update
30th Jun 202111:15 amRNSTotal Voting Rights
26th May 20217:00 amRNSSettlement Agreement reached with Beyond Air
21st May 202110:58 amRNSResult of AGM
21st May 20217:00 amRNSAGM Statement
5th May 20216:30 pmRNSHolding(s) in Company
30th Apr 202112:32 pmRNSTotal Voting Rights
21st Apr 20217:00 amRNSAnnual Report and Notice of AGM
6th Apr 202112:56 pmRNSDirector/PDMR Shareholding
1st Apr 20219:00 amRNSBlock Listing Application
31st Mar 202112:14 pmRNSBlock listing Interim Review
24th Mar 20217:01 amRNSSubscription to raise £5 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.